XML 22 R40.htm IDEA: XBRL DOCUMENT v3.19.3
Stockholders' Equity (Details Textual) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
May 07, 2019
Apr. 29, 2019
May 16, 2016
Sep. 30, 2019
Mar. 31, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Stockholders' Equity (Textual)                
Aggregate fair value of options granted             $ 337,598 $ 708,501
Total unrecognized compensation expense       $ 655,138     $ 655,138  
Weighted average expected recognition period of unrecognized compensation expense             1 year 1 month 6 days  
Stock-based compensation expense             $ 1,233,962 1,205,682
Replacement award of restricted shares       79,286     79,286  
Proceeds from common stock         $ 34,500      
Aggregate intrinsic value of stock options, outstanding       $ 22,173   $ 1,752,348 $ 22,173 1,752,348
Aggregate intrinsic value of stock options, exercisable       $ 9,363   825,048 $ 9,363 825,048
Aggregate granted options to employees, Shares             193,294  
Repurchased shares of common stock   $ 500,000          
Repurchase plan expires date   Apr. 29, 2020            
2016 Plan [Member]                
Stockholders' Equity (Textual)                
Number of stock available for future issuance       420,344     420,344  
Judy Krandel [Member]                
Stockholders' Equity (Textual)                
Stock option transaction, description The Company (i) entered into an option cancellation and release agreement, pursuant to which the Company canceled Ms. Krandel’s option award agreement, dated November 15, 2016, related to the award of a stock option representing the right to purchase 142,857 shares of common stock and (ii) entered into a revised option agreement granting Ms. Krandel a stock option representing the right to purchase up to 142,857 shares of common stock at an exercise price equal to $3.55 per share (the “Revised Option Agreement”). The stock option subject to the Revised Option Agreement vests: (i) 50% on the date of grant, (ii) 25% on May 15, 2019 and (iii) 25% in 12 equal installments on the 15th day of each month, with the first tranche vesting on June 15, 2019 and the last tranche vesting on May 15, 2020. The Company accounted for these agreements as an option modification and recognized approximately $115,000 of stock compensation expense in connection with the agreements.              
Minimum [Member]                
Stockholders' Equity (Textual)                
Stock options, exercise price             $ 3.55  
Maximum [Member]                
Stockholders' Equity (Textual)                
Stock options, exercise price             $ 4.55  
Stock Compensation Plan [Member]                
Stockholders' Equity (Textual)                
Number of shares issued under plan     1,300,000          
Percentage of common stock delivered pursuant to incentive stock options     100.00%          
Stock Compensation Plan One [Member]                
Stockholders' Equity (Textual)                
Number of shares issued under plan     181,604          
Restricted Stock [Member]                
Stockholders' Equity (Textual)                
Stock-based compensation expense       $ 185,374   $ 185,374 $ 556,122 $ 556,122
Vesting shares of restricted stock